Hemp Industry Pioneer to Display Groundbreaking, Low-THC Hemp Oil Cannabidiol Products in U.S. State Poised to Legalize Recreational Use of Marijuana
San Diego, CA – Sept. 07, 2016 – Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds® is exhibiting at the Sept. 7-9 Cannabis World Congress & Business Exposition (CWCBExpo) in Los Angeles, Calif., which is poised to potentially become the 5th U.S. state to legalize marijuana for recreational use.
The Expo, being held at the Los Angeles Convention Center, follows a successful June CWCBExpo in New York that had close to 4,000 attendees. Los Angeles’ CWCBExpo, like its East Coast counterpart, brings together cannabis industry business professionals, investors and those looking to get involved in an industry estimated to top $35 billion annually by 2020.
“As the first publicly traded company in the medical and industrial hemp space, we’re honored to have our HempMeds® products on display in the state in which we’re headquartered and in the state that may be poised to become the 5th U.S. state to legalize recreational marijuana this November when residents vote on Proposition 64 at the ballots,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “It’s an exciting time to be involved in the cannabis industry, the newest multibillion-dollar industry in the U.S., and it’s our goal at conferences like these to educate audiences on the plethora of benefits that cannabis can provide to patients around the world.”
HempMeds® representatives will be exhibiting a wide range of retail-ready cannabis products at booth #505, including its zero-THC Real Scientific Hemp Oil-X™ (RSHO-X™), the first-ever cannabis product to receive approval from the federal government of Mexico for importation. Also on display will be its groundbreaking Real Scientific Hemp Oil™ (RSHO™), which helped reshape international cannabis laws in Paraguay and Brazil. Hemp oil products from HempMeds® are readily available to ship to all 50 U.S. states, districts and territories, plus more than 40 countries around the world.
HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC PINK: MJNA) and the Company’s exclusive master distributor and contracted marketing company, handling sales and distribution.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
Investor Relations Contact:
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: [email protected]